APMD

Apnimed, Inc. - Common Stock (APMD)

About Apnimed, Inc. - Common Stock (APMD)

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Details

Daily high

$22.73

Daily low

$21.10

Price at open

$22.60

52 Week High

$35.29

52 Week Low

$16.00

Market cap

938.4M

Dividend yield

Volume

682,086

Avg. volume

630,692

P/E ratio

Apnimed, Inc. - Common Stock News